Health Canada inspection
KBI Biopharma Inc.: Health Canada inspection of Jun 18, 2024
Health Canada · GMP · rating C
Key facts
| Establishment | KBI Biopharma Inc. |
|---|---|
| City | Durham |
| Province | NC |
| Country | United States |
| Program | GMP |
| Start date | Jun 11, 2024 |
| End date | Jun 18, 2024 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.